Study in Parkinson's Disease Patients with Dyskinesia with Combinations of JM-010 and Its Individual Components (SHINE)

General Information Age Group Adults Status Recruiting Protocol Number BK-JM-201 Background Information Research Question: To compare the efficacy of the study medication to that of placebo therapy in reducing dyskinesia severity in Parkinson's disease. Offered At Inova Medical Group – Neurology 8081 Innovation Park Dr., #900 Fairfax, VA 22031 Eligibility Information Adults, between 18 and 80 years of age at screening visit Is diagnosed with idiopathic PD that meets UK Parkinson's Disease Society (UKPDS) Brain Bank Clinical Diagnostic Criteria Has experienced dyskinesia Has stable peak-effect dyskinesia Has more than one hour of "ON" time with troublesome dyskinesia Ineligibility Information Has undergone surgery for the treatment of PD Has a current diagnosis of substance use Has psychiatric diagnosis of acute psychotic disorder or other psychiatric diagnoses Has current seizure disorders requiring treatment with anticonvulsants. Additional information can be found at: https://clinicaltrials.gov/ct2/show/NCT04377945?term=BK-JM-201&draw=2&rank=1 Contact Information Contact Name Stefannie Belardo, BSN, RN Contact Phone 703-205-2147 Contact Email Send Email